<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00931775</url>
  </required_header>
  <id_info>
    <org_study_id>CIT-PIN_01-0C3</org_study_id>
    <nct_id>NCT00931775</nct_id>
  </id_info>
  <brief_title>Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder</brief_title>
  <acronym>CIT-PIN</acronym>
  <official_title>Citalopram Versus Citalopram Plus Pindolol in Latency of Antidepressant Response Shortening in Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether the speed of the clinical antidepressant
      action of citalopram can be accelerated by administering double doses of pindolol (15 mg/day,
      tid) which presumably should lead to increased 5-HT1A autoreceptor occupancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design, Settings, and Participants. A randomised, double-blind, placebo-controlled trial with
      MDD patients allocated to two treatment arms: citalopram + pindolol versus citalopram +
      placebo. Participants: outpatients with a depressive episode (DSM-IV criteria) were selected
      from a general hospital.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">March 2005</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scores on Hamilton Depression Rating Scale</measure>
    <time_frame>8 time points through 6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>Antidepressant Treatment Response</condition>
  <arm_group>
    <arm_group_label>Citalopram + placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Citalopram 20 mg/day t.i.d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Citalopram + pindolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Citalopram 20 mg/day t.i.d Pindolol 15 mg/day t.i.d.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pindolol</intervention_name>
    <description>Pill orally administered. 15 mg/day t.i.d.</description>
    <arm_group_label>Citalopram + placebo</arm_group_label>
    <arm_group_label>Citalopram + pindolol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a depressive episode

          -  HDRS score &gt; 18

          -  Written informed consent

        Exclusion Criteria:

          -  suicidal risk &gt; 3

          -  severe organic illness

          -  other psychotropic drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enric Álvarez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry. Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Víctor Pérez, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Psychiatry. Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesc Artigas, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Neurochemistry department. Consejo Superior de Investigaciones Científicas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Outpatients Service of Psychiatry Department. Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2009</study_first_submitted>
  <study_first_submitted_qc>July 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2009</study_first_posted>
  <last_update_submitted>July 1, 2009</last_update_submitted>
  <last_update_submitted_qc>July 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Enric Álvarez / Víctor Pérez</name_title>
    <organization>Hospital de la Santa Creu i Sant Pau. Psychiatry Department</organization>
  </responsible_party>
  <keyword>Major depressive disorder, citalopram, pindolol, HDRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
    <mesh_term>Pindolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

